17 Nov 2017 --- Advanced Lipids’ SN-2 infant formula ingredient Infat may have the potential to support healthy bone growth, a study has shown. The study published in Nutrients may be especially interesting for children with special nutritional needs, among others.
Palmitic acid is the most abundant saturated fatty acid in human milk, where it is primarily located in the SN-2 position, Advanced Lipids notes. SN-2 palmitate is a well-established structured fat added to infant formulas. It is already known to offer a range of benefits for babies, including longer sleep duration and reduced crying.
Recently, researchers set out to explore the effect that SN-2 palmitate has on the length and quality of bones in a catch-up growth model. After restricting the diets of two groups of rats, one group was fed with a diet enriched with Infat – Advanced Lipids’ SN-2 palmitate ingredient – and the other with a standard diet.
Weight gain was similar between the two groups and there were no adverse effects from either diet. However, rats in the Infat group scored higher on parameters such as humerus length. Values relating to bone quality also seemed higher in the Infat group, although the difference did not reach statistical significance.
Researchers also analyzed gene expression in the two groups and found that three genes in the liver showed an increase in the Infat group. They say these may be associated with growth and development in the epidermal growth plate.
“Infat is already a well substantiated structured fat for infant formula with multiple clinical studies proving its benefits for infant nutrition,” comments Dr. Sigalit Zchut, Chief Scientist at Advanced Lipids. “However, as an innovative company, Advanced Lipids is testing its effect in other fields as well.”
“This study is exciting because it shows that SN-2 palmitate may have a beneficial effect on the length and quality of bones of mice that were subjected to food restriction, followed by nutrition-induced catch-up growth,” Zchut adds. “Though this is a pre-clinical study, its implications may be important, especially for children with growth disorders and children with special nutritional needs.”
22 Jan 2018 –
The World Health Organization (WHO) has deemed ...
19 Jan 2018 –
Frutarom Industries has completed its ...
18 Jan 2018 –
The European Food and Safety Authority (EFSA) ...
16 Jan 2018 –
Calls for a ban on the sale of energy drinks to ...
15 Jan 2018 –
The European Food Safety Authority (EFSA) has ...